• Home
  • About
      • Back
      • What is InFLAMES?
      • InFLAMES Organization
      • Steering group
      • SIAB
      • Postdocs in Flames (PiF)
      • Infrastructure
  • People
      • Back
      • People
      • Professors of Practice
      • Visiting Professors
      • Bioinformatics team
  • Education
      • Back
      • InFLAMES doctoral module
      • ImmuDocs Education Pilot
  • Output and Impact
      • Back
      • Recent Publications
      • Dissertations
  • News and Events
      • Back
      • News
      • Events
      • Blogs
      • Corporate Corner
      • Events archive
  • Join Us
      • Back
      • Vacancies
      • Partners
      • Why Finland?
  • Contact
      • Back
      • Contact
      • Reservation calendars
      • Research Managers
  • Suomi
  • Home
  • About
      • Back
      • What is InFLAMES?
      • InFLAMES Organization
      • Steering group
      • Scientific and Impact Advisory Board (SIAB)
      • Postdocs in Flames (PiF)
      • Infrastructure
  • People
      • Back
      • People
      • Professors of Practice
      • Visiting Professors
      • Bioinformatics team
  • Education
      • Back
      • InFLAMES doctoral module
      • ImmuDocs – National Doctoral Education Pilot Based on the Immune System
  • Output and Impact
      • Back
      • Recent Publications
      • Dissertations
  • News and events
      • Back
      • News
      • Upcoming events
      • Blogs
      • Corporate Corner
      • Events Archive
  • Join us
      • Back
      • Vacancies
      • Partners
      • Why Finland?
  • Contact us
      • Back
      • Contact
      • Reservation calendars
      • Research managers reservation calendar
  • Suomi

Author: Henok Karvonen

Freshly minted PhD – what’s next?

18 November 2021
Freshly minted PhD – what’s next?

The value of a drug is measured along the way

4 November 2021
The value of a drug is measured along the way

Immunology is on the rise in pharmaceutical trends

21 October 2021

Wins and losses – Does a failed drug development project matter?

7 October 2021

InFLAMES-yhteistyöstä syntynyt syöpälääke patentoitiin USA:ssa

16 June 2021
InFLAMES-yhteistyöstä syntynyt syöpälääke patentoitiin USA:ssa

Hinkuyskä on tiedettyä yleisempi Euroopassa

10 June 2021
Hinkuyskä on tiedettyä yleisempi Euroopassa

Pertussis More Common in Europe than Previously Thought

10 June 2021
Pertussis More Common in Europe than Previously Thought

Novel Antibody Drug Wakes Up the Body’s Defense System in Advanced-stage Cancer

7 June 2021
Novel Antibody Drug Wakes Up the Body’s Defense System in Advanced-stage Cancer

Uusi vasta-ainelääke herättää elimistön puolustusjärjestelmän pitkälle edenneessä syövässä

7 June 2021
Uusi vasta-ainelääke herättää elimistön puolustusjärjestelmän pitkälle edenneessä syövässä

Page 2 of 5

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

About InFLAMES

Home

About us

Education

Output and Impact

Output and Impact

Partners

Information

Join us

Contact us

Join our newsletter mailing list or contact Us:

inflames@utu.fi
Follow us
© InFLAMES Research Flagship 2026